CVA Family Office’s Adient ADNT Stock Holding History

CVA Family Office’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28	Closed	-$632	–	1288
2024 Q3	$632	Buy	28 +10	+56%	+$229	﹤0.01%	1145
2024 Q2	$445	Buy	+18	New	+$511	﹤0.01%	1247

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CVA Family Office's ADNT Position: Q4 2024 in Review

CVA Family Office sold out of Adient (ADNT) in Q4 2024, closing a stake of 28 shares — an estimated $632 sold.

CVA Family Office first reported a position in ADNT in Q2 2024 and held it in 2 quarters. The position peaked at $632 in Q3 2024. 270 funds tracked by Wall St. Rank hold ADNT as of Q4 2024.

CVA Family Office reported no remaining Adient position as of Q4 2024 after selling out during the quarter.
CVA Family Office sold 28 Adient shares in Q4 2024, an estimated $632.
CVA Family Office first reported a position in Adient in Q2 2024 and held it in 2 quarters.
CVA Family Office's Adient position peaked at $632 in Q3 2024.
270 funds tracked by Wall St. Rank held Adient as of Q4 2024.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.